[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $sgmo FDA grants Fast Track designation for ST-503, boosting hopes for pain and Fabry disease treatments. Investors anticipate potential partnerships and positive clinical data, driving significant social media buzz. ### About $sgmo SGMO is a biotechnology company focused on genomic medicine. ### Insights - $sgmo engagements is up XXXXX% from the previous week. ### Engagements: XXXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/interactions.tsv) Current Value: XXXXXX Daily Average: XXXXXX X Week: XXXXXX +25% X Month: XXXXXXX -XX% X Months: XXXXXXXXX -XX% X Year: XXXXXXXXXX +66% 1-Year High: XXXXXXX on 2024-12-31 1-Year Low: XXXXX on 2025-12-06 Engagements by network (24h): X: XXXXXX YouTube: X ### Mentions: XXX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/posts_active.tsv) Current Value: XXX Daily Average: XXX X Week: XXX -XX% X Month: XXXXX +68% X Months: XXXXX -XX% X Year: XXXXXX +150% 1-Year High: XXX on 2025-01-02 1-Year Low: XX on 2025-05-25 Mentions by network (24h): X: XXXXX YouTube: X ### Creators: XXX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/contributors_active.tsv) XXX unique social accounts have posts mentioning $sgmo in the last XX hours which is up XXX% from XX in the previous XX hours Daily Average: XX X Week: XXX -XX% X Month: XXX +188% X Months: XXXXX +169% X Year: XXXXX +162% 1-Year High: XXX on 2025-06-29 1-Year Low: XX on 2025-05-25 The most influential creators that mention $sgmo in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | X | XXXXX | XX | XXXXX | | [@yusufhameed](/creator/twitter/yusufhameed) | X | XXXXX | XX | XXXXX | | [@Franca_ole](/creator/twitter/Franca_ole) | X | XXX | XX | XXXXX | | [@bulpro95856](/creator/twitter/bulpro95856) | X | XX | X | XXXXX | | [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | X | XXX | X | XXX | | [@AnthonyLew81615](/creator/twitter/AnthonyLew81615) | X | XX | X | XXX | | [@truthdotphd](/creator/twitter/truthdotphd) | X | XXXXX | X | XXX | | [@Corona_N_Lyme](/creator/twitter/Corona_N_Lyme) | X | XXXXX | X | XXX | | [@lucas_gs05](/creator/twitter/lucas_gs05) | X | XXXXX | X | XXX | | [@blackswantrader](/creator/twitter/blackswantrader) | XX | XXX | X | XXX | [View More](/list/creators/$sgmo/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% -X% X Month: XX% -XX% X Months: XX% -X% X Year: XX% -XX% 1-Year High: XXX% on 2025-05-19 1-Year Low: XX% on 2025-12-06 Most Supportive Themes: - Upcoming Data and Positive Developments: (60%) Anticipation of upcoming clinical data presentations and potential breakthroughs are driving positive sentiment. - Bullish Sentiment and Recommendations: (30%) Positive sentiment and recommendations from various bloggers and users are contributing to the positive outlook. Most Critical Themes: - Market Volatility and Risks: (10%) Concerns about the stock's performance and potential risks are present. ### Top $sgmo Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "The next $WVE $ARWR $VTYX are in biotech. I think the best is $SGMO. Its pipelines and programs will be worth at least 10x once one of them starts to get bought. And I truly believe $SGMO will return 10x from the current depressed level to $5-$10 in 2026" [X Link](https://x.com/bill_us/status/1998072947131445577) [@bill_us](/creator/x/bill_us) 2025-12-08T16:51Z 2392 followers, 1613 engagements "TOP X ACTIVE WATCHLIST FOR BOTH PORTFOLIOS Growth X. $GOOGL X. $OKLO X. $IREN X. $NBIS X. $ISRG Small-Cap X. $ONDS X. $RR X. $OSCR X. $CIFR X. $PRCT $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL" [X Link](https://x.com/ParadiseTraderr/status/1998042499248693329) [@ParadiseTraderr](/creator/x/ParadiseTraderr) 2025-12-08T14:50Z XXX followers, XXX engagements "$PFE $SGMO Sangamo's gene therapy showed strong Phase X data (superior to standard prophylaxis with durable FVIII expression) potentially offering a more transformative one-and-done alternative for hemophilia A patients without inhibitors. However it's not "better" in practice yetHympavzi is approved accessible and addresses a wider population (including inhibitors and hemophilia B) while gene therapies like giroctocogene face commercialization headwinds (e.g. patient/physician hesitancy high costs and Pfizer's pivot to non-gene options like Hympavzi). Sangamo is optimistic about partnering" [X Link](https://x.com/yusufhameed/status/1998005298066251930) [@yusufhameed](/creator/x/yusufhameed) 2025-12-08T12:22Z 1752 followers, 2664 engagements "@UnionSteel2017 Leme put it this way Once they resolve their cash problem (which i think they wil) Then market will rerate $sgmo based on their platform IMO next year will be big for them" [X Link](https://x.com/Jota5571189851/status/1997998698077282718) [@Jota5571189851](/creator/x/Jota5571189851) 2025-12-08T11:56Z X followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
FDA grants Fast Track designation for ST-503, boosting hopes for pain and Fabry disease treatments. Investors anticipate potential partnerships and positive clinical data, driving significant social media buzz.
SGMO is a biotechnology company focused on genomic medicine.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +25%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX +66%
1-Year High: XXXXXXX on 2024-12-31
1-Year Low: XXXXX on 2025-12-06
Engagements by network (24h): X: XXXXXX YouTube: X
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +68%
X Months: XXXXX -XX%
X Year: XXXXXX +150%
1-Year High: XXX on 2025-01-02
1-Year Low: XX on 2025-05-25
Mentions by network (24h): X: XXXXX YouTube: X
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning $sgmo in the last XX hours which is up XXX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +188%
X Months: XXXXX +169%
X Year: XXXXX +162%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-05-25
The most influential creators that mention $sgmo in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiotechAnalysst | X | XXXXX | XX | XXXXX |
| @yusufhameed | X | XXXXX | XX | XXXXX |
| @Franca_ole | X | XXX | XX | XXXXX |
| @bulpro95856 | X | XX | X | XXXXX |
| @ParadiseTraderr | X | XXX | X | XXX |
| @AnthonyLew81615 | X | XX | X | XXX |
| @truthdotphd | X | XXXXX | X | XXX |
| @Corona_N_Lyme | X | XXXXX | X | XXX |
| @lucas_gs05 | X | XXXXX | X | XXX |
| @blackswantrader | XX | XXX | X | XXX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -X%
X Year: XX% -XX%
1-Year High: XXX% on 2025-05-19
1-Year Low: XX% on 2025-12-06
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"The next $WVE $ARWR $VTYX are in biotech. I think the best is $SGMO. Its pipelines and programs will be worth at least 10x once one of them starts to get bought. And I truly believe $SGMO will return 10x from the current depressed level to $5-$10 in 2026"
X Link @bill_us 2025-12-08T16:51Z 2392 followers, 1613 engagements
"TOP X ACTIVE WATCHLIST FOR BOTH PORTFOLIOS Growth X. $GOOGL X. $OKLO X. $IREN X. $NBIS X. $ISRG Small-Cap X. $ONDS X. $RR X. $OSCR X. $CIFR X. $PRCT $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL"
X Link @ParadiseTraderr 2025-12-08T14:50Z XXX followers, XXX engagements
"$PFE $SGMO Sangamo's gene therapy showed strong Phase X data (superior to standard prophylaxis with durable FVIII expression) potentially offering a more transformative one-and-done alternative for hemophilia A patients without inhibitors. However it's not "better" in practice yetHympavzi is approved accessible and addresses a wider population (including inhibitors and hemophilia B) while gene therapies like giroctocogene face commercialization headwinds (e.g. patient/physician hesitancy high costs and Pfizer's pivot to non-gene options like Hympavzi). Sangamo is optimistic about partnering"
X Link @yusufhameed 2025-12-08T12:22Z 1752 followers, 2664 engagements
"@UnionSteel2017 Leme put it this way Once they resolve their cash problem (which i think they wil) Then market will rerate $sgmo based on their platform IMO next year will be big for them"
X Link @Jota5571189851 2025-12-08T11:56Z X followers, XXX engagements
/topic/$sgmo